Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration

CompletedOBSERVATIONAL
Enrollment

540

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Renal Insufficiency
Trial Locations (27)

Unknown

Covenant Health Care, Saginaw

St. Louis University Medical Center, St Louis

Abington Memorial Hospital, Philadelphia

University of Texas Health Science Center, San Antonio

Hospital Italiano de Buenos Aires, Buenos Aires

UZ Brussel, Brussels

AZ St Lucas, Ghent

H. Hartziekenhuis, Roeselare

Hospital Universitario de San Ignacio, Bogotá

IATM (Instituto de alta tecnologia Medica de Antoquia), Medellín

Hôpital Necker - Enfants malades, Paris

Hôpital Bois-Guillaume - CHU de Rouen, Rouen

Cardioangiologisches Centrum Bethanien, Frankfurt

Institute of Radiology and Neuroradiology, Frankfurt

Instituto Tumori Pascale, Napoli

Ospedale Santa Maria, Pozzuoli

Universita campus Biomedico, Roma

Soonchunhyang Univ. Bucheon Hospital, Gyeonggi-do

Uijeongbu St. Mary's Hospital, Gyeonggi-do

Chung-Ang Univ. Medical Center, Seoul

Ewha Womans University Mokdong Hospital, Seoul

Hospital Clínico San Carlos de Madrid, Madrid

CRC Hospital Universitari Sant Joan de Reus, Reus

Dişkapi Etlik Polikliniği, Ankara

Medeniyet University Goztepe Research and Training Hospital, Istanbul

Royal Liverpool University Hospital, Liverpool

University Hospital of North Staffodshire, Stoke-on-Trent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT01467271 - Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration | Biotech Hunter | Biotech Hunter